News
An antibody treatment successfully prepared patients for stem cell transplants without toxic chemotherapy or radiation.
An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic ...
Researchers have developed a blood test to predict MS onset by measuring EBV antibody levels, potentially allowing early diagnosis and care.
Millions of people experience allergies annually, with about 40% of the global population having at least one allergic ...
With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...
Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.
Semaglutide has surged in popularity over the past two years, thanks to its remarkable effectiveness as a long-acting GLP-1 ...
Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...
"While COPD remains the third leading cause of death worldwide, patients and families have limited treatment options for ...
Arcellx, Inc. advances anito-cel CAR-T therapy for relapsed/refractory multiple myeloma. Click for ACLX pivotal trials, FDA ...
1d
News-Medical.Net on MSNMuscle loss from GLP-1 drugs could undermine long-term healthPopular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results